Therapeutically active alpha MSH analogues
    2.
    发明授权
    Therapeutically active alpha MSH analogues 失效
    治疗活性αMSH类似物

    公开(公告)号:US08466104B2

    公开(公告)日:2013-06-18

    申请号:US12064923

    申请日:2005-08-26

    IPC分类号: A61K38/24 C07K14/68

    摘要: The invention describes peptide analogues of a-melanocyte-stimulating hormone (a-MSH), which posses an increased efficacy compared to the native α-MSH peptide. The α-MSH analogues exhibit increased anti-inflammatory effects and increased capability to prevent ischemic conditions compared to α-MSH. The invention further discloses use of the peptides for the manufacture of pharmaceutical compositions for the treatment or prophylaxis of a condition in the tissue of one or more organs of a mammal, and moreover pharmaceutical compositions.

    摘要翻译: 本发明描述了与天然α-MSH肽相比具有增加的功效的α-黑素细胞刺激激素(a-MSH)的肽类似物。 与α-MSH相比,α-MSH类似物表现出增加的抗炎作用和增强的预防缺血状况的能力。 本发明进一步公开了该肽用于制备用于治疗或预防哺乳动物的一种或多种器官的组织中的病症的药物组合物的用途,以及药物组合物。

    THERAPEUTICALLY ACTIVE ALPHA MSH ANALOGUES
    3.
    发明申请
    THERAPEUTICALLY ACTIVE ALPHA MSH ANALOGUES 失效
    治疗活性阿尔法MSH类似物

    公开(公告)号:US20090069242A1

    公开(公告)日:2009-03-12

    申请号:US12064923

    申请日:2005-08-26

    IPC分类号: A61K38/00 C07K7/00 A61P9/00

    摘要: The invention describes peptide analogues of a-melanocyte-stimulating hormone (a-MSH), which posses an increased efficacy compared to the native α-MSH peptide. The α-MSH analogues exhibit increased anti-inflammatory effects and increased capability to prevent ischemic conditions compared to α-MSH. The invention further discloses use of the peptides for the manufacture of pharmaceutical compositions for the treatment or prophylaxis of a condition in the tissue of one or more organs of a mammal, and moreover pharmaceutical compositions.

    摘要翻译: 本发明描述了与天然α-MSH肽相比具有增加的功效的α-黑素细胞刺激激素(a-MSH)的肽类似物。 与α-MSH相比,α-MSH类似物表现出增加的抗炎作用和增强的预防缺血状况的能力。 本发明进一步公开了该肽用于制备用于治疗或预防哺乳动物的一种或多种器官的组织中的病症的药物组合物的用途,以及药物组合物。